BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38572511)

  • 1. Administration of adiponectin receptor agonist AdipoRon relieves cancer cachexia by mitigating inflammation in tumour-bearing mice.
    Massart IS; Kouakou AN; Pelet N; Lause P; Schakman O; Loumaye A; Abou-Samra M; Deldicque L; Bindels LB; Brichard SM; Thissen JP
    J Cachexia Sarcopenia Muscle; 2024 Apr; ():. PubMed ID: 38572511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic-pituitary-adrenal axis activation and glucocorticoid-responsive gene expression in skeletal muscle and liver of Apc mice.
    Martin A; Castells J; Allibert V; Emerit A; Zolotoff C; Cardot-Ruffino V; Gallot YS; Vernus B; Chauvet V; Bartholin L; Schaeffer L; Durieux AC; Hourdé C; Favier FB; Mazelin L; Freyssenet D
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1686-1703. PubMed ID: 35277933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of aryl hydrocarbon receptor signalling promotes hepatic disorders in cancer cachexia.
    Dolly A; Pötgens SA; Thibaut MM; Neyrinck AM; de Castro GS; Galbert C; Lefevre C; Wyart E; Gomes SP; Gonçalves DC; Lanthier N; Baldin P; Huot JR; Bonetto A; Seelaender M; Delzenne NM; Sokol H; Bindels LB
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1569-1582. PubMed ID: 37127348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia.
    Chiappalupi S; Sorci G; Vukasinovic A; Salvadori L; Sagheddu R; Coletti D; Renga G; Romani L; Donato R; Riuzzi F
    J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):929-946. PubMed ID: 32159297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
    Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
    J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
    Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle NAD
    Hulmi JJ; Penna F; Pöllänen N; Nissinen TA; Hentilä J; Euro L; Lautaoja JH; Ballarò R; Soliymani R; Baumann M; Ritvos O; Pirinen E; Lalowski M
    Mol Metab; 2020 Nov; 41():101046. PubMed ID: 32599075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a traditional Chinese medicine-based agent for the treatment of cancer cachexia.
    Wu KC; Chu PC; Cheng YJ; Li CI; Tian J; Wu HY; Wu SH; Lai YC; Kao HH; Hsu AL; Lin HW; Lin CH
    J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2073-2087. PubMed ID: 35718751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AdipoRon, a new therapeutic prospect for Duchenne muscular dystrophy.
    Abou-Samra M; Selvais CM; Boursereau R; Lecompte S; Noel L; Brichard SM
    J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):518-533. PubMed ID: 31965757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p97-Nploc4 ATPase complex plays a role in muscle atrophy during cancer and amyotrophic lateral sclerosis.
    Re Cecconi AD; Barone M; Gaspari S; Tortarolo M; Bendotti C; Porcu L; Terribile G; Piccirillo R
    J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2225-2241. PubMed ID: 35611892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia.
    Ham DJ; Murphy KT; Chee A; Lynch GS; Koopman R
    Clin Nutr; 2014 Jun; 33(3):448-58. PubMed ID: 23835111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerobic and resistance training dependent skeletal muscle plasticity in the colon-26 murine model of cancer cachexia.
    Khamoui AV; Park BS; Kim DH; Yeh MC; Oh SL; Elam ML; Jo E; Arjmandi BH; Salazar G; Grant SC; Contreras RJ; Lee WJ; Kim JS
    Metabolism; 2016 May; 65(5):685-698. PubMed ID: 27085776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway.
    Shen Q; Kuang JX; Miao CX; Zhang WL; Li YW; Zhang XW; Liu X
    Phytomedicine; 2022 Jan; 95():153858. PubMed ID: 34861585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic signal transducer and activator of transcription-3 signalling drives early-stage pancreatic cancer cachexia via suppressed ketogenesis.
    Arneson-Wissink PC; Mendez H; Pelz K; Dickie J; Bartlett AQ; Worley BL; Krasnow SM; Eil R; Grossberg AJ
    J Cachexia Sarcopenia Muscle; 2024 Apr; ():. PubMed ID: 38632714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.
    Brown JL; Rosa-Caldwell ME; Lee DE; Blackwell TA; Brown LA; Perry RA; Haynie WS; Hardee JP; Carson JA; Wiggs MP; Washington TA; Greene NP
    J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):926-938. PubMed ID: 28845591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of modified ceramides are a defining feature of murine and human cancer cachexia.
    Morigny P; Zuber J; Haid M; Kaltenecker D; Riols F; Lima JDC; Simoes E; Otoch JP; Schmidt SF; Herzig S; Adamski J; Seelaender M; Berriel Diaz M; Rohm M
    J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1459-1475. PubMed ID: 33090732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse.
    Aulino P; Berardi E; Cardillo VM; Rizzuto E; Perniconi B; Ramina C; Padula F; Spugnini EP; Baldi A; Faiola F; Adamo S; Coletti D
    BMC Cancer; 2010 Jul; 10():363. PubMed ID: 20615237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism.
    Pin F; Barreto R; Couch ME; Bonetto A; O'Connell TM
    J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):140-154. PubMed ID: 30680954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voluntary exercise does not improve muscular properties or functional capacity during C26-induced cancer cachexia in mice.
    Hiroux C; Dalle S; Koppo K; Hespel P
    J Muscle Res Cell Motil; 2021 Jun; 42(2):169-181. PubMed ID: 33606189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL-6 and tumour-derived extracellular vesicles.
    Fan M; Gu X; Zhang W; Shen Q; Zhang R; Fang Q; Wang Y; Guo X; Zhang X; Liu X
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2724-2739. PubMed ID: 36085573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.